BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23261207)

  • 1. Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis.
    Zaidat OO; Castonguay AC; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Eliasziw M; Thomas Megerian J; Shetty S; Yoklavich Guilhermier M; Barnwell S; Smith WS; Gress DR;
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1131-9. PubMed ID: 23261207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.
    Zaidat OO; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Megerian JT; Lesko J; Pitzer P; Ramos J; Castonguay AC; Barnwell S; Smith WS; Gress DR;
    JAMA; 2015 Mar 24-31; 313(12):1240-8. PubMed ID: 25803346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
    Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
    Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.
    Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI
    Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elective treatment of intracranial stenosis with the balloon-expandable Pharos Vitesse stent: 30-day stroke rate and complications.
    von Schoenfeldt P; Krützelmann A; Bußmeyer M; Mpotsaris A; Rosenkranz M; Fiehler J; Weber W; Buhk JH
    J Neurointerv Surg; 2015 Mar; 7(3):188-93. PubMed ID: 24510379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High risk of recurrent ischemic events among patients with deferred intracranial angioplasty and stent placement for symptomatic intracranial atherosclerosis.
    Kozak O; Tariq N; Suri MF; Taylor RA; Qureshi AI
    Neurosurgery; 2011 Aug; 69(2):334-42; discussion 342-3. PubMed ID: 21430591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China.
    Gao P; Zhao Z; Wang D; Wu J; Cai Y; Li T; Wu W; Shi H; He W; Zhu F; Jiao L; Ling F
    Interv Neuroradiol; 2015 Apr; 21(2):196-204. PubMed ID: 25934656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thirty-Day Outcome of a Multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China.
    Miao Z; Zhang Y; Shuai J; Jiang C; Zhu Q; Chen K; Liu L; Li B; Shi X; Gao L; Liu Y; Wang F; Li Y; Liu T; Zheng H; Wang Y; Wang Y;
    Stroke; 2015 Oct; 46(10):2822-9. PubMed ID: 26286544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angioplasty And stenting For symptomatic intracranial atherosclerotic disease: How I Do It.
    Mekonnen EA; Tekle WG; Desai SK; Hassan AE
    Interv Neuroradiol; 2023 Aug; 29(4):459-465. PubMed ID: 35331035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Prospective Trial of Stent Placement in Patients with Symptomatic High-Grade Intracranial Stenosis.
    Gao P; Wang D; Zhao Z; Cai Y; Li T; Shi H; Wu W; He W; Yin L; Huang S; Zhu F; Jiao L; Ji X; Qureshi AI; Ling F
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1275-80. PubMed ID: 26869472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial.
    Compter A; van der Worp HB; Schonewille WJ; Vos JA; Boiten J; Nederkoorn PJ; Uyttenboogaart M; Lo RT; Algra A; Kappelle LJ;
    Lancet Neurol; 2015 Jun; 14(6):606-14. PubMed ID: 25908089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Transluminal Angioplasty with Stent Placement versus Best Medical Therapy Alone in Symptomatic Intracranial Arterial Stenosis: A Best Evidence Review.
    Padalia A; Sambursky JA; Skinner C; Moureiden M
    Cureus; 2018 Jul; 10(7):e2988. PubMed ID: 30397562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of high risk symptomatic intracranial atherosclerosis with balloon mounted coronary stents and Wingspan stents: single center experience over a 10 year period.
    Tarlov N; Jahan R; Saver JL; Sayre JW; Ali LK; Kim D; Duckwiler GR; Tateshima S; Viñuela F; Liebeskind DS
    J Neurointerv Surg; 2012 Jan; 4(1):34-9. PubMed ID: 21990460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis.
    Jiang WJ; Xu XT; Du B; Dong KH; Jin M; Wang QH; Ma N
    Neurology; 2007 Feb; 68(6):420-6. PubMed ID: 17283316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting.
    Jiang WJ; Yu W; Du B; Gao F; Cui LY
    Stroke; 2011 Jul; 42(7):1971-5. PubMed ID: 21636814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations.
    Qureshi AI; Al-Senani FM; Husain S; Janjua NA; Lanzino G; Lavados PM; Nguyen T; Raymond J; Shah QA; Suarez JI; Suri MF; Tolun R
    J Neuroimaging; 2012 Jan; 22(1):1-13. PubMed ID: 22250951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial.
    Gao P; Wang T; Wang D; Liebeskind DS; Shi H; Li T; Zhao Z; Cai Y; Wu W; He W; Yu J; Zheng B; Wang H; Wu Y; Dmytriw AA; Krings T; Derdeyn CP; Jiao L;
    JAMA; 2022 Aug; 328(6):534-542. PubMed ID: 35943472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise.
    Salik AE; Selcuk HH; Zalov H; Kilinc F; Cirak M; Kara B
    Interv Neuroradiol; 2019 Oct; 25(5):484-490. PubMed ID: 30991867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic intracranial stenosis: best medical treatment vs. intracranial stenting.
    Lutsep HL
    Curr Opin Neurol; 2009 Feb; 22(1):69-74. PubMed ID: 19155764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center.
    Miao ZR; Feng L; Li S; Zhu F; Ji X; Jiao L; Ling F
    Neurosurgery; 2009 Jan; 64(1):79-84; discussion 84-5. PubMed ID: 19050657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.